Summary: Researchers have developed a standardized library of mouse embryonic stem cells carrying 63 genetic variants strongly associated with autism spectrum disorder (ASD). Using a combination of precise CRISPR gene editing and established stem cell techniques, the team produced both diverse cell types and live mice with these modifications, enabling consistent study of ASD-related changes at cellular and whole-organism levels.
Comprehensive analyses of these models revealed a recurring problem: many ASD-linked mutations disrupt neurons’ ability to remove malformed proteins, pointing to impaired protein quality control and translational machinery as a shared vulnerability. This well-characterized cell bank is now available as a shareable resource to accelerate research into autism and related neuropsychiatric conditions.
Key Facts:
- Cell Library Created: 63 genetically edited mouse embryonic stem cell lines modeling autism-associated variants.
- Shared Mechanism: Mutations commonly compromise neurons’ protein quality control and translational regulation.
- Wide Applicability: The resource supports studies of ASD and other neuropsychiatric disorders such as schizophrenia and bipolar disorder.
Source: Kobe University
Although genetic influences on autism spectrum disorder are well established, identifying precise cellular mechanisms and shared pathways across diverse mutations has been challenging. Reliable experimental models are essential: cell models reveal how genetic changes affect cell structure and function, while animal models link those cellular alterations to physiology and behavior.
Despite species differences, many genes implicated in human neurodevelopmental disorders are highly conserved in mice and produce comparable effects. A longstanding limitation, however, has been the absence of a standardized, flexible biological platform to compare the effects of many different autism-associated variants under consistent conditions.
To address this gap, neuroscientist TAKUMI Toru and colleagues at Kobe University combined traditional mouse embryonic stem cell manipulation with CRISPR gene editing. Over a twelve-year effort, they optimized methods to efficiently generate multiple genetic variants in embryonic stem cells capable of differentiating into virtually any cell type.
The result is a curated bank of 63 mouse embryonic stem cell lines that represent copy-number variations and other genetic changes most strongly associated with ASD. The researchers validated these lines by differentiating them into a broad spectrum of neural and non-neural cell types and by producing adult mice carrying selected variants to confirm in vivo relevance.
Large-scale molecular profiling, including single-cell RNA sequencing on representative lines, enabled the team to map which genes and pathways are dysregulated and in which specific cell types those changes occur. This approach revealed cell-type-specific susceptibilities and highlighted common vulnerabilities across distinct genetic variants.
A notable and recurring finding was reduced expression of Upf3b in both glutamatergic and GABAergic neurons. UPF3B is a core component of the translation termination and nonsense-mediated mRNA decay (NMD) pathway, which is central to maintaining protein quality and controlling aberrant translation products. Dysfunction of this translational machinery during development may therefore contribute to neuronal defects seen in ASD.
Takumi emphasizes that the cell bank’s standardized design makes it straightforward to integrate with other laboratory techniques and to adapt for additional targets. Because many of the genetic variants modeled are also implicated in schizophrenia and bipolar disorder, the resource has broad potential to inform mechanistic studies and to support target discovery for early interventions across neuropsychiatric disorders.
Funding: This research received support from the Japan Society for the Promotion of Science (multiple grants), the Japan Agency for Medical Research and Development, the Japan Science and Technology Agency, the National Center of Neurology and Psychiatry, the Takeda Science Foundation, the Smoking Research Foundation, and several other foundations and institutions. Collaborators included researchers from RIKEN centers, Radboud University, the Agency for Science, Technology and Research, and Hiroshima University.
About this genetics and Autism research news
Author: Daniel Schenz
Source: Kobe University
Contact: Daniel Schenz – Kobe University
Image: The image is credited to Neuroscience News
Original Research: Open access. “ES cell models of autism with copy number variations reveal cell-type-specific translational vulnerability” by TAKUMI Toru et al., published in Cell Genomics.
Abstract
ES cell models of autism with copy number variations reveal cell-type-specific translational vulnerability
Human genetics has identified numerous copy-number variations (CNVs) associated with autism spectrum disorders (ASDs). A major obstacle to understanding shared cellular features of ASD has been the lack of standardized biological resources for systematic comparison.
To fill this need, the authors established a resource of 63 genetically modified mouse embryonic stem cell (ESC) lines representing ASD-linked variants. They performed neural differentiation on a subset of representative lines and applied comprehensive analyses, including single-cell transcriptomics, to uncover pathways vulnerable in specific cell types.
A consistent phenotype emerged in both excitatory glutamatergic and inhibitory GABAergic neurons: reduced expression of Upf3b, a critical component of the translation termination and nonsense-mediated decay (NMD) system. This points to a potential role of translational dysfunction and impaired protein quality control in the developing nervous system as contributors to ASD.
By providing an extensible ESC model bank suitable for in vitro and in vivo experiments, this resource aims to support mechanistic studies of ASD and other neuropsychiatric disorders and to aid efforts to identify targets for early therapeutic intervention.